ADMA Biologics Ownership | Who Owns ADMA Biologics?


OverviewRevenueFinancialsChartTranscripts

ADMA Biologics Ownership Summary


ADMA Biologics is owned by 85.39% institutional investors, 2.97% insiders, and 11.63% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 16.26% of ADMA shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.37% of its assets in ADMA Biologics shares.

ADMA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockADMA Biologics85.39%2.97%11.63%
SectorHealthcare Stocks 57.43%9.41%33.16%
IndustryBiotech Stocks 69.02%8.92%22.06%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de38.15M16.26%$654.27M
Blackrock18.64M8.15%$208.45M
Vanguard group18.20M7.76%$312.11M
State street14.87M6.34%$255.03M
Invesco11.30M4.82%$193.73M
Geode capital management5.43M2.32%$93.19M
Awm investment company5.10M2.23%$56.99M
Morgan stanley4.60M2.01%$51.41M
Dimensional fund advisors lp4.67M1.99%$80.07M
Nuveen asset management4.55M1.94%$78.07M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Stonepine capital management1.24M17.18%$21.28M
Awm investment company5.10M7.70%$56.99M
Altium capital management lp1.40M6.79%$23.92M
Ophir asset management pty1.34M3.43%$23.01M
Oberweis asset management inc/3.34M2.70%$57.32M
New millennium group214.31K2.15%$3.68M
First turn management684.23K2.10%$11.73M
Mesirow institutional investment management782.45K1.03%$13.42M
Miura global management50.00K0.94%$857.50K
Eam global investors277.15K0.85%$4.75M

Top Buyers

HolderShares% AssetsChange
Perpetual3.63M0.73%3.63M
Allspring global investments2.84M0.08%2.61M
State street14.87M0.01%1.87M
Fmr3.20M0.00%1.25M
Raymond james financial1.11M0.01%1.11M

Top Sellers

HolderShares% AssetsChange
Assenagon asset management591.68K0.02%-2.88M
D. e. shaw3.07M0.04%-2.20M
Bank of montreal /can/26.56K0.00%-2.06M
Nuveen asset management4.55M0.02%-2.03M
Velan capital investment management lp---1.53M

New Positions

HolderShares% AssetsChangeValue
Perpetual3.63M0.73%3.63M$62.30M
Raymond james financial1.11M0.01%1.11M$19.08M
Tang capital management550.00K0.62%550.00K$9.43M
Royce & associates lp420.57K0.07%420.57K$7.21M
Simplify asset management385.19K0.33%385.19K$6.61M

Sold Out

HolderChange
Mendota financial group-4.00
Ancora advisors-100.00
Reuter james wealth management-117.00
Abich financial wealth management-177.00
Innealta capital-213.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20243213.55%200,305,365-3.74%851.09%1961.55%992.06%
Sep 30, 202430920.23%208,056,49715.00%881.42%19329.53%9618.52%
Jun 30, 202425517.51%180,834,8813.64%791.33%1497.97%8053.85%
Mar 31, 202421716.67%174,477,0703.15%771.37%13850.00%52-10.34%
Dec 31, 2023186-1.59%169,142,481-1.14%751.27%92-16.36%5826.09%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF15.07M6.37%7.79K
Vanguard Total Stock Mkt Idx Inv7.02M2.97%16.85K
iShares Russell 2000 ETF5.87M2.48%-115.00K
SPDR® S&P Biotech ETF5.50M2.33%41.50K
Vanguard Institutional Extnd Mkt Idx Tr3.59M1.52%948.00
Xtrackers MSCI World Swap ETF 1C3.15M1.33%-
T. Rowe Price Integrated US SmCapGrEq3.05M1.29%1.53M
CREF Stock R12.80M1.20%-102.61K
Fidelity Small Cap Index2.28M0.97%-19.42K
iShares S&P Small-Cap 600 Growth ETF2.18M0.92%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 22, 2024Tade Brad L. CFO and TreasurerSell$317.25K
Nov 22, 2024Grossman Adam S President and CEOSell$1.03M
Sep 09, 2024Guiheen Lawrence P.-Sell$166.19K
Aug 30, 2024Kestenberg-Messina Kaitlin M. COO and SVP, ComplianceSell$408.05K
Aug 29, 2024Grossman Jerrold B-Sell$2.36M

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q4-2
2024 Q3-6
2024 Q2-1
2024 Q1-5

ADMA Ownership FAQ


Who Owns ADMA Biologics?

ADMA Biologics shareholders are primarily institutional investors at 85.39%, followed by 2.97% insiders and 11.64% retail investors. The average institutional ownership in ADMA Biologics's industry, Biotech Stocks , is 69.02%, which ADMA Biologics exceeds.

Who owns the most shares of ADMA Biologics?

ADMA Biologics’s largest shareholders are Blackrock funding, inc. /de (38.15M shares, 16.26%), Blackrock (18.64M shares, 8.15%), and Vanguard group (18.2M shares, 7.76%). Together, they hold 32.17% of ADMA Biologics’s total shares outstanding.

Does Blackrock own ADMA Biologics?

Yes, BlackRock owns 8.15% of ADMA Biologics, totaling 18.64M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 208.45M$. In the last quarter, BlackRock increased its holdings by 445.43K shares, a 2.45% change.

Who is ADMA Biologics’s biggest shareholder by percentage of total assets invested?

Stonepine capital management is ADMA Biologics’s biggest shareholder by percentage of total assets invested, with 17.18% of its assets in 1.24M ADMA Biologics shares, valued at 21.28M$.

Who is the top mutual fund holder of ADMA Biologics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of ADMA Biologics shares, with 6.37% of its total shares outstanding invested in 15.07M ADMA Biologics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools